Patents by Inventor Byung-Kil Choi

Byung-Kil Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230291819
    Abstract: A flexible display device is disclosed. The flexible display device comprises a first body, a second body, a flexible display, and a speaker. The first body includes a deco frame, a first sound radiation unit, and a second sound radiation unit. The first sound radiation unit and the second sound radiation unit form an outlet through which the sound (sound waves) of the speaker is transmitted to the outside of the first body. The flexible display includes a first region fixed to the first body, and is provided with the second sound radiation unit while the outer surface of the border portion of the first region is spaced apart from the deco frame. The sound (sound waves) of the speaker is transmitted to the outside of the first body through the first sound radiation unit and the second sound radiation unit, such that the sound quality of the speaker can be improved, and the second sound radiation unit can be prevented from being exposed to the outside.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 14, 2023
    Applicant: LG ELECTRONICS INC.
    Inventors: Tae Hwan JEON, Dong Uk JEONG, Byung Kil CHOI
  • Publication number: 20040097534
    Abstract: Disclosed is a composition for protecting nerve cells, promoting nerve cell growth and regenerating nerve cells comprising berberine, derivatives thereof or pharmaceutically acceptable salts thereof. The composition has protective effects against apoptosis of neuronal stem cells and differentiated neuronal stem cells, an effect of inducing the regeneration of nerve cells, a regenerative effect on neurites, a neuroregenerative effect on central nerves and peripheral nerves, a reformation effect on neuromuscular junctions, and a protective effect against apoptosis of nerve cells and a neuroregenerative effect in animals suffering from dementia and brain ischemia. Therefore, the composition can be used as a therapeutic agent for the prevention and treatment of neurodegenerative diseases, ischemic nervous diseases or nerve injuries, and for the improvement of learning capability.
    Type: Application
    Filed: March 14, 2003
    Publication date: May 20, 2004
    Applicant: EUGENBIO INC.
    Inventors: Byung-Kil Choi, Yun-Hee Kim, Soo-Kyung Kim, Jung-Su Lim, Hyo-Sup Kim, Dae-Sung Park, Chi-Young Chang